Toxicity and management in CAR T-cell therapy
Top Cited Papers
Open Access
- 1 January 2016
- journal article
- review article
- Published by Elsevier BV in Molecular Therapy Oncolytics
- Vol. 3, 16011
- https://doi.org/10.1038/mto.2016.11
Abstract
No abstract availableKeywords
This publication has 79 references indexed in Scilit:
- Chimeric Antigen Receptor–Modified T Cells for Acute Lymphoid LeukemiaThe New England Journal of Medicine, 2013
- Inducible Apoptosis as a Safety Switch for Adoptive Cell TherapyThe New England Journal of Medicine, 2011
- T Cells Targeting Carcinoembryonic Antigen Can Mediate Regression of Metastatic Colorectal Cancer but Induce Severe Transient ColitisMolecular Therapy, 2011
- Antitransgene Rejection Responses Contribute to Attenuated Persistence of Adoptively Transferred CD20/CD19-Specific Chimeric Antigen Receptor Redirected T Cells in HumansTransplantation and Cellular Therapy, 2010
- Case Report of a Serious Adverse Event Following the Administration of T Cells Transduced With a Chimeric Antigen Receptor Recognizing ERBB2Molecular Therapy, 2010
- Manufacturing Validation of Biologically Functional T Cells Targeted to CD19 Antigen for Autologous Adoptive Cell TherapyJournal of Immunotherapy, 2009
- Adoptive cell transfer: a clinical path to effective cancer immunotherapyNature Reviews Cancer, 2008
- Inducible Caspase 9 Suicide Gene to Improve the Safety of Allodepleted T Cells after Haploidentical Stem Cell TransplantationTransplantation and Cellular Therapy, 2007
- Preparing clinical grade Ag-specific T cells for adoptive immunotherapy trialsCytotherapy, 2007
- Occurrence of leukaemia following gene therapy of X-linked SCIDNature Reviews Cancer, 2003